These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

253 related items for PubMed ID: 17544551

  • 1. Co-immunisation with DNA encoding RANK/RANKL or 4-1BBL costimulatory molecules does not enhance effector or memory CTL responses afforded by immunisation with a tumour antigen-encoding DNA vaccine.
    Herd KA, Wiethe C, Tindle RW.
    Vaccine; 2007 Jul 09; 25(28):5209-19. PubMed ID: 17544551
    [Abstract] [Full Text] [Related]

  • 2. Provision of 4-1BB ligand enhances effector and memory CTL responses generated by immunization with dendritic cells expressing a human tumor-associated antigen.
    Wiethe C, Dittmar K, Doan T, Lindenmaier W, Tindle R.
    J Immunol; 2003 Mar 15; 170(6):2912-22. PubMed ID: 12626542
    [Abstract] [Full Text] [Related]

  • 3. The adjuvant effects of co-stimulatory molecules on cellular and memory responses to HBsAg DNA vaccination.
    Du X, Zheng G, Jin H, Kang Y, Wang J, Xiao C, Zhang S, Zhao L, Chen A, Wang B.
    J Gene Med; 2007 Feb 15; 9(2):136-46. PubMed ID: 17310492
    [Abstract] [Full Text] [Related]

  • 4. Cotransfection of dendritic cells with RNA coding for HER-2/neu and 4-1BBL increases the induction of tumor antigen specific cytotoxic T lymphocytes.
    Grünebach F, Kayser K, Weck MM, Müller MR, Appel S, Brossart P.
    Cancer Gene Ther; 2005 Sep 15; 12(9):749-56. PubMed ID: 15877082
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Enhanced CTL responses mediated by plasmid DNA immunogens encoding costimulatory molecules and cytokines.
    Iwasaki A, Stiernholm BJ, Chan AK, Berinstein NL, Barber BH.
    J Immunol; 1997 May 15; 158(10):4591-601. PubMed ID: 9144471
    [Abstract] [Full Text] [Related]

  • 11. Anti-class II antibodies, but not cytotoxic T-lymphocyte antigen 4-immunoglobulin hybrid molecules, prevent rejection of major histocompatibility complex class II-negative myeloma in T-cell receptor-transgenic mice.
    Dembic Z, Hofgaard PO, Omholt H, Bogen B.
    Scand J Immunol; 2004 May 15; 60(1-2):143-52. PubMed ID: 15238083
    [Abstract] [Full Text] [Related]

  • 12. Costimulation provided by DNA immunization enhances antitumor immunity.
    Corr M, Tighe H, Lee D, Dudler J, Trieu M, Brinson DC, Carson DA.
    J Immunol; 1997 Nov 15; 159(10):4999-5004. PubMed ID: 9366427
    [Abstract] [Full Text] [Related]

  • 13. Endoplasmic reticulum targeting sequence enhances HBV-specific cytotoxic T lymphocytes induced by a CTL epitope-based DNA vaccine.
    Xu W, Chu Y, Zhang R, Xu H, Wang Y, Xiong S.
    Virology; 2005 Apr 10; 334(2):255-63. PubMed ID: 15780875
    [Abstract] [Full Text] [Related]

  • 14. Engineering enhancement of the immune response to HBV DNA vaccine in mice by the use of LIGHT gene adjuvant.
    Zhang Y, Jiang W, Fan Y, Wen J, Hao W, Qian M.
    J Virol Methods; 2008 Nov 10; 153(2):142-8. PubMed ID: 18722475
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Intramuscular immunization with plasmid coexpressing tumour antigen and Flt-3L results in potent tumour regression.
    Fong CL, Mok CL, Hui KM.
    Gene Ther; 2006 Feb 10; 13(3):245-56. PubMed ID: 16163376
    [Abstract] [Full Text] [Related]

  • 18. Co-stimulation with 4-1BB ligand allows extended T-cell proliferation, synergizes with CD80/CD86 and can reactivate anergic T cells.
    Habib-Agahi M, Phan TT, Searle PF.
    Int Immunol; 2007 Dec 10; 19(12):1383-94. PubMed ID: 17977894
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Vaccination with a DNA vaccine based on human PSCA and HSP70 adjuvant enhances the antigen-specific CD8+ T-cell response and inhibits the PSCA+ tumors growth in mice.
    Zhang X, Yu C, Zhao J, Fu L, Yi S, Liu S, Yu T, Chen W.
    J Gene Med; 2007 Aug 10; 9(8):715-26. PubMed ID: 17595048
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.